🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Asymptomatic Brain Metastases

A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases NCT05033691NA1 site📍 Jerusalem Hadassah Medical Organization · Tests: Stereotactic surgery Tarlatamab for SCLC Brain Metastases NCT07402343Phase 24 sites📍 Amsterdam📍 Groningen📍 Maastricht Maastricht University Medical Center · Tests: Tarlatamab Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer NCT04348747Phase 23 sites📍 Tampa📍 Buffalo📍 Charlottesville Roswell Park Cancer Institute · Tests: Anti-HER2/HER3 Dendritic Cell Vaccine, Pembrolizumab Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements NCT05987644Phase 1, Phase 23 sites📍 Stanford📍 Aurora📍 Columbus Joshua Palmer · Tests: Alectinib, Stereotactic Radiosurgery Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases NCT06712927Phase 21 site📍 Palo Alto Stanford University · Tests: Ipilimumab, Nivolumab + Relatlimab FDC Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT NCT05236946Phase 31 site📍 Mumbai Tata Memorial Hospital · Tests: Stereotactic radiosurgery/whole brain radiotherapy, Tyrosine kinase inhibitor Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer NCT05522660Phase 315 sites📍 Naples📍 Padova📍 Perugia ETOP IBCSG Partners Foundation · Tests: Stereotactic radiosurgery, Immune checkpoint inhibitor Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases NCT06401824Phase 23 sites📍 Amsterdam📍 Groningen📍 Maastricht Maastricht University Medical Center · Tests: Sacituzumab Govitecan-Hziy 180 MG plus bevacizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy